The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Long-course preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study
Open accessAbstract
BACKGROUND This trial evaluated whether preoperative short-course radiotherapy and consolidation chemotherapy (CCT) were superior to chemoradiation in rectal cancers with clinical (c)T4 or fixed cT3. Previously, we reported early results showing no differences in the radical surgery rate (primary end-point). In the short-course/CCT group, we observed lower acute toxicity of preoperative treatment and better overall survival (OS). We updated results to determine whether the benefit in OS was sustained and to evaluate late complications. PATIENTS AND METHODS Patients with cT4 or fixed cT3 rectal cancer were randomized either to preoperative 5 × 5 Gy and three cycles of FOLFOX4 or to chemoradiation (50.4 Gy with bolus 5-Fu, leucovorin and oxaliplatin). RESULTS 515 patients were eligible for analysis, 261 in the short-course/CCT group and 254 in the chemoradiation group. The median follow-up was 7.0 years. The difference in OS was insignificant, HR = 0.90 (95% confidence interval [CI] 0.70-1.15), P = 0.38. However, the difference in early OS favouring short-course/CCT previously reported was observed again, being 9% at 3 years (95% CI 0.5%-17%). This difference disappeared later; at 8 years OS was 49% in both groups. There was no difference in disease-free survival, HR = 0.95 (95% CI 0.75-1.19), P = 0.65, at 8 years 43% vs. 41% in the short-course/CCT group vs. the chemoradiation group, respectively. The corresponding values for cumulative incidences of local failure and distant metastases did not differ and were HR = 1.08, 95% CI 0.70-1.23, P = 0.60, 35% vs. 32% and HR = 1.10, 95% CI 0.68-1.23, P = 0.54, 36% vs. 34%, respectively. The rate of late complications was similar (P = 0.66), grade 3+ being 11% vs. 9% in the short-course/CCT group vs. the chemoradiation group, respectively. CONCLUSION The superiority of preoperative short-course/CCT over chemoradiation was not demonstrated. CLINICAL TRIAL NUMBER The trial is registered as ClinicalTrials.gov number NCT00833131.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cox, J. D., Stetz, J., & Pajak, T. F. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00060-c · Cited by 4,792
O'Connell, M. J., Martenson, J. A., Wieand, H. S., Krook, J. E., Macdonald, J. S., Haller, D. G., Mayer, R. J., Gunderson, L. L., & Rich, T. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408253310803 · Cited by 1,136
Aschele, C., Cionini, L., Lonardi, S., Pinto, C., Cordio, S., Rosati, G., Artale, S., Tagliagambe, A., Ambrosini, G., Rosetti, P., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.4911 · Cited by 763
Brændengen, M., Tveit, K. M., Berglund, Å., Birkemeyer, E., Frykholm, G., Påhlman, L., Wiig, J. N., Byström, P., Bujko, K., & Glimelius, B. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.3858 · Cited by 476
Self-citationBujko, K., Wyrwicz, L., Rutkowski, A., Malinowska, M., Pietrzak, L., Kryński, J., Michalski, W., Olędzki, J., Kuśnierz, J., Zając, L., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw062 · Cited by 439
Self-citationNilsson, P. J., van Etten, B., Hospers, G. A., Påhlman, L., van de Velde, C. J., Beets-Tan, R. G., Blomqvist, L., Beukema, J. C., Kapiteijn, E., Marijnen, C. A., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-279 · Cited by 293
Short-course preoperative radiotherapy with delayed surgery in rectal cancer – A retrospective study
Radu, C., Berglund, Å., Påhlman, L., & Glimelius, B. (2008) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.11.025 · Cited by 217
Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer
Pettersson, D., Lörinc, E., Holm, T., Iversen, H., Cedermark, B., Glimelius, B., & Martling, A. (2015) · British Journal of Surgery · doi:10.1002/bjs.9811 · Cited by 204
Smalley, S. R., Benedetti, J. K., Williamson, S. K., Robertson, J. M., Estes, N. C., Maher, T., Fisher, B., Rich, T. A., Martenson, J. A., Kugler, J. W., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.9544 · Cited by 164
Markovina, S. T., Youssef, F. F., Roy, A., Aggarwal, S., Khwaja, S. S., DeWees, T. A., Tan, B. R., Hunt, S. R., Myerson, R. J., Chang, D. T., et al. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.05.048 · Cited by 99
Cited by
Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Benson, A. B., Venook, A. P., Al-Hawary, M. M., Azad, N., Chen, Y.-J., Ciombor, K. K., Cohen, S., Cooper, H. S., Deming, D., Garrido-Laguna, I., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0051 · Cited by 827
Jin, J., Tang, Y., Hu, C., Jiang, L.-M., Jiang, J., Li, N., Liu, W.-Y., Chen, S.-L., Li, S., Lu, N.-N., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.01667 · Cited by 505
Fokas, E., Schlenska-Lange, A., Polat, B., Klautke, G., Grabenbauer, G. G., Fietkau, R., Kuhnt, T., Staib, L., Brunner, T., Grosu, A.-L., et al. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2021.5445 · Cited by 360
Marijnen, C. A. M., Peters, F. P., Rödel, C., Bujko, K., Haustermans, K., Fokas, E., Glynne-Jones, R., Valentini, V., Spindler, K.-L. G., Guren, M. G., et al. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.03.039 · Cited by 78
Self-citation
Metadata
- Authors
- Ciseł, B., Pietrzak, L., Michalski, W., Wyrwicz, L., Rutkowski, A., Kosakowska, E., Cencelewicz, A., Spałek, M., Polkowski, W., Jankiewicz, M., Styliński, R., Bębenek, M., Kapturkiewicz, B., Maciejczyk, A., Sadowski, J., Zygulska, J., Zegarski, W., Jankowski, M., Las-Jankowska, M., Toczko, Z., Żelazowska-Omiotek, U., Kępka, L., Socha, J., Wasilewska-Tesluk, E., Markiewicz, W., Kładny, J., Majewski, A., Kapuściński, W., Suwiński, R., & Bujko, K.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2019-08
- Volume
- 30
- Issue
- 8
- Pages
- 1298-1303
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2949733640
- Cited by
- 320
- References
- 14
- FWCI
- 11.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-course preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study. https://app.cochat.ai/papers/10.1093/annonc/mdz186
- The paper
- Ciseł, B., Pietrzak, L., Michalski, W., Wyrwicz, L., Rutkowski, A., Kosakowska, E., Cencelewicz, A., Spałek, M., Polkowski, W., Jankiewicz, M., Styliński, R., Bębenek, M., Kapturkiewicz, B., Maciejczyk, A., Sadowski, J., Zygulska, J., Zegarski, W., Jankowski, M., Las-Jankowska, M., . . . Bujko, K. (2019). Long-course preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study. Annals of Oncology. https://doi.org/10.1093/annonc/mdz186
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.